What is Michael Wiederkehr's NPI number?

Michael Wiederkehr's National Provider Identifier (NPI) is 1396759783, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Michael Wiederkehr's specialty?

Michael Wiederkehr is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Michael Wiederkehr located?

Michael Wiederkehr's practice location on file with NPPES is 1 W Ridgewood Ave, Paramus, NJ 07652-2359.

What is Michael Wiederkehr's phone number?

The practice phone number listed in the NPPES registry for Michael Wiederkehr is (201) 857-4200.

Does Michael Wiederkehr accept Medicare?

Michael Wiederkehr is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Michael Wiederkehr's NPI active?

Yes — Michael Wiederkehr's NPI (1396759783) is active in the NPPES registry as of the last update on 2026-04-16.

IndividualActiveAccepts Medicare

Michael Wiederkehr, MD

NPI 1396759783 · Dermatology Physician · Paramus, NJ

Michael Wiederkehr, MD is a Dermatology Physician provider in Paramus, NJ (NPI 1396759783).

Provider details

NPI number: 1396759783
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: MA069839 (NJ)

Practice location

1 W Ridgewood Ave

Suite 103

Paramus, NJ 07652-2359

Phone: (201) 857-4200

Fax: (201) 857-4199

Street-level locationGet directions

More NJ providers

Mailing address

1 W Ridgewood Ave Ste 103

Paramus, NJ 07652-2361

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense MA069839 (NJ)
Allopathic & Osteopathic Physicians

Additional practice locations (2)

80 River St Ste 4a
Hoboken, NJ 07030-5619
Phone: (201) 857-4200
217 Brook Ave Ste B108
Passaic, NJ 07055-3357
Phone: (201) 857-4200
Fax: (201) 857-4199

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(97/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
3 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
6,380 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,761	$8
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,495	$102
Biopsy of Related Skin Growth, First Growth11102	754	$104
Destruction of Precancer Skin Growth, 1 Growth17000	742	$58
Destruction of Skin Growth, 1-14 Growths17110	347	$128
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	93	63
Triamcinolone Acetonide	67	58
Hydrocortisone	64	51
Fluorouracil	49	47
Metronidazole	45	24
Doxycycline Hyclate	36	20
Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented	35	27
Mupirocin	35

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$906 across 57 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-07-28
Last updated: 2026-04-16
Certified: 2026-04-16

Frequently asked questions

What is Michael Wiederkehr's NPI number?: Michael Wiederkehr's National Provider Identifier (NPI) is 1396759783, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Michael Wiederkehr's specialty?: Michael Wiederkehr is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Michael Wiederkehr located?: Michael Wiederkehr's practice location on file with NPPES is 1 W Ridgewood Ave, Paramus, NJ 07652-2359.
What is Michael Wiederkehr's phone number?: The practice phone number listed in the NPPES registry for Michael Wiederkehr is (201) 857-4200.
Does Michael Wiederkehr accept Medicare?: Michael Wiederkehr is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Michael Wiederkehr's NPI active?: Yes — Michael Wiederkehr's NPI (1396759783) is active in the NPPES registry as of the last update on 2026-04-16.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,761	$8
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,495	$102
Biopsy of Related Skin Growth, First Growth11102	754	$104
Destruction of Precancer Skin Growth, 1 Growth17000	742	$58
Destruction of Skin Growth, 1-14 Growths17110	347	$128
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	93	63
Triamcinolone Acetonide	67	58
Hydrocortisone	64	51
Fluorouracil	49	47
Metronidazole	45	24
Doxycycline Hyclate	36	20
Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented	35	27
Mupirocin	35

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$906 across 57 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (2)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (2)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments